What You Should Know:
- DTx and Patient Support leaders, Amalgam Rx, Inc., announce the acquisition of Avhana Health, a privately-held clinical decision support (CDS) company.
Amalgam Rx, Inc., a Wilmington,
DE-based Digital Therapeutics and Patient Support company, announces the acquisition
of Avhana Health, a privately held
clinical decision support (CDS) company, which has deep integrations with the
leading electronic health records (EHR). As part of the acquisition, Amalgam
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know:
- Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population.
- Vida’s diabetes management program
achieves lasting results for participants. Because chronic conditions like diabetes,
obesity, and hypertension often occur simultaneously, Vida’s unique program was
built from the ground up to treat multiple conditions at the same time.
- The new partnership, which will
Read More
Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health
What You Should Know:
- Cerner Corporation today announced with Xealth new
centralized digital ordering and monitoring for health systems, starting with
Banner Health, to foster digital innovation.
- Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address areas such as chronic disease management, behavioral health, maternity care, and surgery prep.
Cerner, today announced it’s building on the recent collaboration with
Read More
Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms
What You Should Know:
- Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities.
- In 28 days, Freespira can reduce or eliminate panic
attacks and PTSD symptoms from home with just a tablet, sensor, and custom app.
There’s no medicine with possible side effects and no need
Read More
Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics
What You Should Know:
- Pear Therapeutics today announced that it has
successfully closed an $80 million Series D financing led by SoftBank Vision
Fund 2.
- Pear is the
leader in prescription digital therapeutics and the first company to receive
FDA authorization for a prescription digital therapeutic (PDT) to treat
disease.
- Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More
Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care
What You Should Know:
- Brigham is working with Biofourmis on a national
rollout of their co-developed technology solution, which has been refined and
scaled for use by other healthcare systems across the country seeking to
establish and execute similar home hospital programs to alleviate COVID-related
capacity issues and to receive 1:1 parity on payments from CMS.
- The Hospital@HomeTM platform provides a turnkey,
end-to-end ecosystem for any health system that wants to quickly launch
Read More
UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications
What You Should Know:
- UCB has selected Medisafe to develop branded digital
drug companions for antiepileptic medications, marking the company’s official
entry into the digital therapeutics space.
- The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its use for additional brands.
Medisafe,
a leading digital
therapeutics company specializing in digital companions, has been selected
by UCB to develop branded digital
Read More
DarioHealth Selected as Digital Chronic Care Solution by Self Insured, Fortune 500 Company
What You Should Know:
- DarioHealth Corp., a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible employees of a U.S.-based Fortune 500 technology company.
- Dario's top-rated digital diabetes tools and coaching will
be available to eligible employees and their dependents starting January 1,
2021
- Dario helps manage and improve the health of people living
with chronic conditions such
Read More
Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health
What You Should Know:
- Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management.
- Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization.
AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all
Read More
Redox Integrates Voluntis’ Digital Therapeutics Within EHR
What You Should Know:
- Voluntis forms a strategic partnership with Redox to integrate Voluntis' digital therapeutics within existing clinical workflows and EHRs.
- Integration of Voluntis’ Theraxium platform with the
Redox Engine used by more than 900 healthcare organizations using 55 EHRs
across the country.
- The first area of this application will be in oncology,
with future extensions in other therapeutic areas. As a result, clinical staff
will be better equipped to serve each
Read More
